{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:11:46Z","timestamp":1793675506615,"version":"4.5.1"},"reference-count":6,"publisher":"MJS Publishing, Medical Journals Sweden AB","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Oncologica"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1080\/02841860310023165","type":"journal-article","created":{"date-parts":[[2004,4,2]],"date-time":"2004-04-02T12:07:32Z","timestamp":1080907652000},"page":"186-189","source":"Crossref","is-referenced-by-count":43,"title":["Oral capecitabine in anthracycline- and taxane-pretreated advanced\/metastatic breast cancer"],"prefix":"10.2340","volume":"43","author":[{"given":"Erik A.","family":"Wist","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde H.","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rn","family":"\u00d8stenstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terje","family":"Risberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yngve","family":"Bremnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingvild","family":"Mjaaland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2009,7,8]]},"reference":[{"key":"CIT0001","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1200\/JCO.2002.20.4.894","volume":"20","author":"Diasio RB","year":"2002","journal-title":"J Clin Oncol"},{"key":"CIT0002","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0959-8049(98)00058-6","volume":"34","author":"Miwa M","year":"1998","journal-title":"Eur J Cancer"},{"key":"CIT0003","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1200\/JCO.1999.17.2.485","volume":"17","author":"Blum JL","year":"1999","journal-title":"J Clin Oncol"},{"key":"CIT0004","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/1097-0142(20011001)92:7<1759::AID-CNCR1691>3.0.CO;2-A","volume":"92","author":"Blum JL","year":"2001","journal-title":"Cancer"},{"key":"CIT0008","first-page":"110","volume":"15","author":"Liu G","year":"1997","journal-title":"Warner E. Patient preferences for oral versus intravenous palliative chemotherapy. J Clin Oncol"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(01)00371-9"}],"container-title":["Acta Oncologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/02841860310023165","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T18:05:34Z","timestamp":1756404334000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/view\/26910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":6,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2009,7,8]]},"published-print":{"date-parts":[[2004,3]]}},"alternative-id":["10.1080\/02841860310023165"],"URL":"https:\/\/doi.org\/10.1080\/02841860310023165","relation":{},"ISSN":["0284-186X","1651-226X"],"issn-type":[{"value":"0284-186X","type":"print"},{"value":"1651-226X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}